Why This Inovio Analyst Is Reducing Estimates For The Coronavirus Vaccine DeveloperBenzinga • 08/11/20
Stock Markets Take Late-Day Hit; Inovio, Novavax Plunge on Coronavirus Vaccine ConcernsThe Motley Fool • 08/11/20
Why Dynavax Technologies, Heat Biologics, and Inovio Pharmaceuticals Are Cratering TodayThe Motley Fool • 08/11/20
Stifel cuts COVID-19 vaccine developer Inovio's price target as earnings and call leave more questions than answersMarket Watch • 08/11/20
T Cell Responses To Coronavirus Vaccines Are In The Interest Of National SecuritySeeking Alpha • 08/10/20
INOVIO Reports Second Quarter 2020 Financial Results; Provides DNA Medicines Clinical Program Mid-Year UpdatePRNewsWire • 08/10/20
Why The Coronavirus Pandemic Could Influence Biotech Stocks For Years To ComeInvestors Business Daily • 07/30/20
Inovio Coronavirus Vaccine Study Shows Months Of Immunity In Primates, Sending Stock HigherBenzinga • 07/30/20